SAIPROXA

This brand name is authorized in Nigeria.

Active ingredients

The drug SAIPROXA contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8581	Tablet	SAIPROXA TABLETS TAB 500 mg 1 X 10	5 CMS-PP-235134 SAIPROXA TABLETS Ciprofloxacin Tablets USP 500mg Ciprofloxacin Hydrochloride USP Equivalent to ciprofloxacin 500mg Maize Starch 302.22mg Sodium Starch Glycolate 7.84mg Sodium Methyl Paraben 15.04mg Sodium Propyl Paraben 0.12mg Purified Talc 12.16mg Magnesium Stearate 11.37mg Colloidal Anhydrous Silica 1.49mg Sodium Carboxyl Methyl Cellulose 6.85mg Sodium Lauryl Sulphate 1.63mg Instacoat 16.63mg Purified water Q.S B4-8581 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 110tabs POM 1 10/25/2021 SAI SAGAR PHARMA LTD, KAARA STREET, OFF OSOLO WAY, AJAO ESTATE, LAGOS ISOLO LAGOS 8023173150 saisagarltd@gmail.com Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, off Oba Akran Avenue, Ikeja, Lagos, Nigeria	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8581